Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 1 · 25%GRADE not reported 0 · 0%Very low 2 · 50%Low 0 · 0%Moderate 1 · 25%High 0 · 0%

SSRI antidepressants vs tricyclic antidepressants (TCAs)

Diabetes · Adults with mental disorders in low‐ and middle‐income countries

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

SSRI antidepressants vs tricyclic antidepressants (TCAs)

Drop‐out Objective · Adults with mental disorders in low‐ and middle‐income countries

It is very uncertain whether SSRI antidepressants changes drop‐outs (12 weeks) compared with TCA (very low certainty).

1 finding from 1 review

Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
RR 0.34 [0.11, 1.01]
1 study · 25 participants
Very low

SSRI antidepressants vs tricyclic antidepressants (TCAs)

Fasting blood glucose (mg/dL) · Adults with mental disorders in low‐ and middle‐income countries

1 finding from 1 review

Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 141 participants
Moderate

SSRI antidepressants vs tricyclic antidepressants (TCAs)

Body‐mass index (BMI) · Adults with mental disorders in low‐ and middle‐income countries

1 finding from 1 review

Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 18 participants
Very low